The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have launched a call for evidence to evaluate resources developed under the Wellcome-funded Digital Mental Health Technologies (DMHT) programme. The survey opened on 5 November 2026 and will remain open until 26 February 2027.
The call is open to developers and manufacturers of digital mental health technologies, healthcare professionals, researchers, policymakers, regulators, people with lived experience of mental health conditions, carers and members of the public. Stakeholders are encouraged to take part whether they have engaged extensively, minimally or not at all with the existing resources.
The survey forms part of the programme’s Phase 1 evaluation. MHRA and NICE aim to assess how the resources have been received and used across the sector, and whether they have influenced users’ knowledge, confidence, decision-making and professional practice.
The resources were developed to support the safe development, regulation, evaluation and adoption of digital mental health technologies, including mental health apps and other digital tools. Findings will help determine whether Phase 1 outputs have achieved their intended objectives and will inform the future direction of Phase 2.
According to the agencies, the feedback will identify strengths, highlight areas for improvement and shape future work to improve the safety and effectiveness of digital mental health technologies.